COLL FY 2022 Earnings — Collegium Pharmaceutical, Inc. Revenue & Financial Results | Market Cap Arena

COLLCollegium Pharmaceutical, Inc.

$1B

FY 2022 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$464M+67.6% YoY

Gross Profit

$209M45.2% margin

Operating Income

$33M7.2% margin

Net Income

-$25M-5.4% margin

EPS (Diluted)

$-0.74

Cash Flow

Operating Cash Flow

$124M

Free Cash Flow

$123M

Stock-Based Comp.

$23M

Balance Sheet

Total Assets

$1.2B

Total Liabilities

$979M

Stockholders' Equity

$195M

Cash & Equivalents

$174M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$464M	$277M	+67.6%
Gross Profit	$209M	$151M	+39.1%
Operating Income	$33M	$18M	+89.0%
Net Income	-$25M	$72M	-135.0%